The genomic features associated with high-risk multiple myeloma

por Walker, Brian A., Morgan, Gareth J.
Publicado 2018

Laryngeal Actinomycosis Presenting as Foreign Body

por Walker, Brian A., Gerber, Mark E.
Publicado 2022

Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway

por Liu, Enze, Becker, Nathan, Sudha, Parvathi, Dong, Chuanpeng, Liu, Yunlong, Keats, Jonathan, Morgan, Gareth, Walker, Brian A.
Publicado 2023

Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma

por Liu, Enze, Sudha, Parvathi, Becker, Nathan, Jaouadi, Oumaima, Suvannasankha, Attaya, Lee, Kelvin, Abonour, Rafat, Abu Zaid, Mohammad, Walker, Brian A.
Publicado 2023

TarPan: an easily adaptable targeted sequencing panel viewer for research and clinical use

por Ashby, Cody, Rutherford, Michael, Bauer, Michael A., Peterson, Erich A., Wang, Yan, Boyle, Eileen M., Wardell, Christopher P., Walker, Brian A.
Publicado 2020

Differential RNA splicing as a potentially important driver mechanism in multiple myeloma

por Bauer, Michael A., Ashby, Cody, Wardell, Christopher, Boyle, Eileen M., Ortiz, Maria, Flynt, Erin, Thakurta, Anjan, Morgan, Gareth, Walker, Brian A.
Publicado 2020

Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma

por Nguyen, Hong Phuong, Le, Anh Quynh, Liu, Enze, Cesarano, Annamaria, DiMeo, Francesco, Perna, Fabiana, Kapur, Reuben, Walker, Brian A., Tran, Ngoc Tung
Publicado 2023

Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma

por Nguyen, Hong Phuong, Le, Anh Quynh, Liu, Enze, Cesarano, Annamaria, DiMeo, Francesco, Perna, Fabiana, Kapur, Reuben, Walker, Brian A., Tran, Ngoc Tung
Publicado 2023

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma

por Qiang, Ya-Wei, Ye, Shiqiao, Huang, Yuhua, Chen, Yu, Van Rhee, Frits, Epstein, Joshua, Walker, Brian A., Morgan, Gareth J., Davies, Faith E.
Publicado 2018

High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation

por Rico, Daniel, Kent, Daniel, Karataraki, Nefeli, Mikulasova, Aneta, Berlinguer-Palmini, Rolando, Walker, Brian A., Javierre, Biola M., Russell, Lisa J., Brackley, Chris A.
Publicado 2022

Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma

por Di Martino, Maria Teresa, Guzzi, Pietro Hiram, Caracciolo, Daniele, Agnelli, Luca, Neri, Antonino, Walker, Brian A., Morgan, Gareth J., Cannataro, Mario, Tassone, Pierfrancesco, Tagliaferri, Pierosandro
Publicado 2015

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

por Pawlyn, Charlotte, Loehr, Andrea, Ashby, Cody, Tytarenko, Ruslana, Deshpande, Shayu, Sun, James, Fedorchak, Kyle, Mughal, Tariq, Davies, Faith E., Walker, Brian A., Morgan, Gareth J.
Publicado 2018

A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA

por Kozarewa, Iwanka, Rosa-Rosa, Juan Manuel, Wardell, Christopher P., Walker, Brian A., Fenwick, Kerry, Assiotis, Ioannis, Mitsopoulos, Costas, Zvelebil, Marketa, Morgan, Gareth J., Ashworth, Alan, J., Christopher
Publicado 2012

The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway

por Smith, Emma M., Zhang, Lei, Walker, Brian A., Davenport, Emma L., Aronson, Lauren I., Krige, David, Hooftman, Leon, Drummond, Alan H., Morgan, Gareth J., Davies, Faith E.
Publicado 2013

Correction: A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA

por Kozarewa, Iwanka, Rosa-Rosa, Juan Manuel, Wardell, Christopher P., Walker, Brian A., Fenwick, Kerry, Assiotis, Ioannis, Mitsopoulos, Costas, Zvelebil, Marketa, Morgan, Gareth J., Ashworth, Alan, Lord, Christopher J.
Publicado 2012

Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer

por Ghamlouch, Hussein, Boyle, Eileen M., Blaney, Patrick, Wang, Yubao, Choi, Jinyoung, Williams, Louis, Bauer, Michael, Auclair, Daniel, Bruno, Benedetto, Walker, Brian A., Davies, Faith E., Morgan, Gareth J.
Publicado 2021

Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma

por Johnson, Travis S., Sudha, Parvathi, Liu, Enze, Blaney, Patrick, Morgan, Gareth, Chopra, Vivek S., Santos, Cedric Dos, Nixon, Michael, Huang, Kun, Suvannasankha, Attaya, Zaid, Mohammad Abu, Abonour, Rafat, Walker, Brian A.
Publicado 2023

Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients

por Chen, Duojiao, Abu Zaid, Mohammad I., Reiter, Jill L., Czader, Magdalena, Wang, Lin, McGuire, Patrick, Xuei, Xiaoling, Gao, Hongyu, Huang, Kun, Abonour, Rafat, Walker, Brian A., Liu, Yunlong
Publicado 2021

Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma

por Dong, Chuanpeng, Cesarano, Annamaria, Bombaci, Giuseppe, Reiter, Jill L., Yu, Christina Y., Wang, Yue, Jiang, Zhaoyang, Zaid, Mohammad Abu, Huang, Kun, Lu, Xiongbin, Walker, Brian A., Perna, Fabiana, Liu, Yunlong
Publicado 2021

A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue

por Wu, Ping, Walker, Brian A., Broyl, Annemiek, Kaiser, Martin, Johnson, David C., Kuiper, Rowan, van Duin, Mark, Gregory, Walter M., Davies, Faith E., Brewer, Daniel, Hose, Dirk, Sonneveld, Pieter, Morgan, Gareth J.
Publicado 2015